2003
DOI: 10.1523/jneurosci.23-20-07710.2003
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination

Abstract: We examined the role of IGF signaling in the remyelination process by disrupting the gene encoding the type 1 IGF receptor (IGF1R) specifically in the mouse brain by Cre-mediated recombination and then exposing these mutants and normal siblings to cuprizone. This neurotoxicant induces a demyelinating lesion in the corpus callosum that is reversible on termination of the insult. Acute demyelination and oligodendrocyte depletion were the same in mutants and controls, but the mutants did not remyelinate adequatel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
119
0
2

Year Published

2006
2006
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 158 publications
(124 citation statements)
references
References 46 publications
3
119
0
2
Order By: Relevance
“…Although IGF-I reduces the loss of oligodendrocytes when transgenically overexpressed, mice lacking the IGF-I receptor within oligodendrocytes fail to show any acceleration in cuprizone-mediated loss of oligodendrocytes, displaying deficiencies confined to the subsequent remyelination phase (21,25). These findings, in combination with our observations that the loss of oligodendrocytes is exacerbated in LIF Ϫ/Ϫ mice, suggest that LIFR signaling is an important endogenous mechanism for limiting oligodendroglial injury and loss in vivo.…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…Although IGF-I reduces the loss of oligodendrocytes when transgenically overexpressed, mice lacking the IGF-I receptor within oligodendrocytes fail to show any acceleration in cuprizone-mediated loss of oligodendrocytes, displaying deficiencies confined to the subsequent remyelination phase (21,25). These findings, in combination with our observations that the loss of oligodendrocytes is exacerbated in LIF Ϫ/Ϫ mice, suggest that LIFR signaling is an important endogenous mechanism for limiting oligodendroglial injury and loss in vivo.…”
Section: Discussionsupporting
confidence: 55%
“…Although a number of cytokine systems influence the remyelination phase after cuprizone-mediated demyelination, including TNF-␣, IGF-I, FGF-2, and IL-1␤ (22)(23)(24)(25), less is known about the cytokines that modulate the initial loss of oligodendrocytes. Although IGF-I reduces the loss of oligodendrocytes when transgenically overexpressed, mice lacking the IGF-I receptor within oligodendrocytes fail to show any acceleration in cuprizone-mediated loss of oligodendrocytes, displaying deficiencies confined to the subsequent remyelination phase (21,25).…”
Section: Discussionmentioning
confidence: 99%
“…Finally, late endosomes fuse with the lysosomal compartment (Tjelle et al (Mason et al 2003;Zeger et al 2007); Neuronal development (Schlueter et al 2007) ErbB4…”
Section: Endocytosis and Endosomal Targetingmentioning
confidence: 99%
“…The role of IGF1 through its receptor IGF1R signaling in the CNS and in vitro-cultured CNS cells has been well established [36][37][38][39]. In particular, IGF1R signaling is required for normal in vivo oligodendrocyte development and myelination and inhibits mature oligodendrocyte apoptosis during primary demyelination [36][37][38][39]. Thus, if IGF1R is the target of miRNA Let-7b as predicted, then the up-regulation of Let-7b in MHV-infected oligodendrocytes will down regulate the expression of IGF1R, thereby promoting apoptosis of mature oligodendrocyte and preventing myelination/remyelination and differentiation.…”
Section: Discussionmentioning
confidence: 99%